Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endovascular Procedures | 10 | 2025 | 334 | 2.560 |
Why?
|
| Peripheral Arterial Disease | 9 | 2025 | 101 | 2.340 |
Why?
|
| Blood Vessel Prosthesis Implantation | 9 | 2025 | 235 | 2.100 |
Why?
|
| Lower Extremity | 5 | 2025 | 99 | 1.600 |
Why?
|
| Aortic Rupture | 3 | 2025 | 52 | 1.190 |
Why?
|
| Decision Support Techniques | 4 | 2025 | 185 | 1.190 |
Why?
|
| Ischemia | 3 | 2025 | 252 | 1.150 |
Why?
|
| Aortic Aneurysm, Thoracic | 3 | 2025 | 97 | 1.140 |
Why?
|
| Vascular Grafting | 3 | 2024 | 18 | 1.110 |
Why?
|
| Aortic Aneurysm, Abdominal | 5 | 2022 | 119 | 1.080 |
Why?
|
| Aorta, Thoracic | 2 | 2024 | 148 | 0.950 |
Why?
|
| Pseudomonas aeruginosa | 5 | 2012 | 199 | 0.860 |
Why?
|
| Pseudomonas Infections | 4 | 2012 | 94 | 0.850 |
Why?
|
| Frail Elderly | 1 | 2024 | 92 | 0.810 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2024 | 72 | 0.810 |
Why?
|
| Frailty | 1 | 2024 | 94 | 0.760 |
Why?
|
| Healthcare Disparities | 2 | 2025 | 496 | 0.640 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2025 | 619 | 0.620 |
Why?
|
| Risk Factors | 15 | 2025 | 5901 | 0.580 |
Why?
|
| Blood Vessel Prosthesis | 6 | 2024 | 242 | 0.530 |
Why?
|
| Treatment Outcome | 14 | 2025 | 9074 | 0.510 |
Why?
|
| Risk Assessment | 10 | 2025 | 2434 | 0.500 |
Why?
|
| Time Factors | 10 | 2025 | 5379 | 0.450 |
Why?
|
| Postoperative Complications | 7 | 2024 | 2552 | 0.420 |
Why?
|
| Retrospective Studies | 15 | 2025 | 10132 | 0.390 |
Why?
|
| Aged, 80 and over | 10 | 2025 | 7039 | 0.390 |
Why?
|
| Aneurysm | 1 | 2013 | 57 | 0.380 |
Why?
|
| Peritonitis | 1 | 2012 | 28 | 0.370 |
Why?
|
| Databases, Factual | 3 | 2025 | 1004 | 0.360 |
Why?
|
| Opportunistic Infections | 1 | 2012 | 57 | 0.360 |
Why?
|
| Adhesins, Bacterial | 1 | 2012 | 36 | 0.350 |
Why?
|
| Lectins | 1 | 2012 | 82 | 0.350 |
Why?
|
| Sepsis | 3 | 2012 | 382 | 0.340 |
Why?
|
| Hepatectomy | 1 | 2012 | 177 | 0.340 |
Why?
|
| Morphine | 1 | 2012 | 127 | 0.330 |
Why?
|
| Intestines | 3 | 2012 | 433 | 0.330 |
Why?
|
| Popliteal Artery | 2 | 2023 | 30 | 0.300 |
Why?
|
| Aged | 14 | 2025 | 20399 | 0.300 |
Why?
|
| Limb Salvage | 2 | 2024 | 38 | 0.270 |
Why?
|
| Stents | 3 | 2022 | 406 | 0.260 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 825 | 0.250 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 515 | 0.250 |
Why?
|
| Emergencies | 2 | 2024 | 120 | 0.250 |
Why?
|
| Sex Factors | 3 | 2025 | 1102 | 0.250 |
Why?
|
| Prosthesis Design | 4 | 2022 | 293 | 0.240 |
Why?
|
| Middle Aged | 12 | 2025 | 27540 | 0.230 |
Why?
|
| Predictive Value of Tests | 3 | 2025 | 1704 | 0.230 |
Why?
|
| Humans | 24 | 2025 | 93138 | 0.220 |
Why?
|
| Socioeconomic Factors | 2 | 2024 | 627 | 0.220 |
Why?
|
| Punctures | 1 | 2024 | 28 | 0.220 |
Why?
|
| Artificial Limbs | 1 | 2024 | 17 | 0.210 |
Why?
|
| Male | 15 | 2025 | 44357 | 0.210 |
Why?
|
| Heart Valve Prosthesis | 1 | 2024 | 94 | 0.210 |
Why?
|
| Aortic Diseases | 1 | 2024 | 87 | 0.200 |
Why?
|
| Female | 15 | 2025 | 48544 | 0.200 |
Why?
|
| Saphenous Vein | 1 | 2023 | 59 | 0.200 |
Why?
|
| Random Allocation | 3 | 2012 | 308 | 0.200 |
Why?
|
| Geriatric Assessment | 1 | 2024 | 187 | 0.190 |
Why?
|
| Virulence | 3 | 2012 | 273 | 0.190 |
Why?
|
| Acute Disease | 1 | 2024 | 838 | 0.190 |
Why?
|
| Aortic Valve | 1 | 2024 | 250 | 0.190 |
Why?
|
| Recovery of Function | 1 | 2024 | 340 | 0.190 |
Why?
|
| Workload | 1 | 2023 | 126 | 0.180 |
Why?
|
| Myocardial Infarction | 1 | 2025 | 375 | 0.180 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1160 | 0.170 |
Why?
|
| Self Expandable Metallic Stents | 1 | 2020 | 7 | 0.170 |
Why?
|
| Aortography | 1 | 2020 | 57 | 0.160 |
Why?
|
| Situs Inversus | 1 | 2020 | 16 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 59 | 0.160 |
Why?
|
| Jehovah's Witnesses | 1 | 2020 | 21 | 0.160 |
Why?
|
| Aortic Aneurysm | 1 | 2020 | 70 | 0.160 |
Why?
|
| Upper Extremity | 1 | 2020 | 64 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 162 | 0.140 |
Why?
|
| Surgeons | 1 | 2023 | 292 | 0.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2020 | 458 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 2 | 2023 | 151 | 0.130 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2018 | 875 | 0.130 |
Why?
|
| Phosphates | 3 | 2012 | 161 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 606 | 0.120 |
Why?
|
| Physicians | 1 | 2021 | 668 | 0.100 |
Why?
|
| Mice | 6 | 2012 | 12224 | 0.100 |
Why?
|
| Caenorhabditis elegans | 3 | 2012 | 245 | 0.100 |
Why?
|
| Brachial Artery | 1 | 2013 | 37 | 0.100 |
Why?
|
| Aneurysm, False | 1 | 2013 | 52 | 0.100 |
Why?
|
| Social Determinants of Health | 2 | 2024 | 106 | 0.100 |
Why?
|
| Femoral Artery | 1 | 2013 | 90 | 0.090 |
Why?
|
| Axilla | 1 | 2013 | 109 | 0.090 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 121 | 0.090 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2012 | 85 | 0.090 |
Why?
|
| Algorithms | 1 | 2020 | 1948 | 0.090 |
Why?
|
| Candida albicans | 1 | 2012 | 32 | 0.090 |
Why?
|
| Leiomyomatosis | 1 | 2012 | 15 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2012 | 74 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2012 | 113 | 0.080 |
Why?
|
| Phenotype | 3 | 2012 | 2545 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 296 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2012 | 3430 | 0.080 |
Why?
|
| Vena Cava, Inferior | 1 | 2012 | 139 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 148 | 0.080 |
Why?
|
| Metagenome | 1 | 2011 | 116 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 196 | 0.080 |
Why?
|
| Intestine, Small | 1 | 2011 | 311 | 0.080 |
Why?
|
| Endoleak | 2 | 2021 | 42 | 0.070 |
Why?
|
| Critical Illness | 1 | 2012 | 342 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2011 | 245 | 0.070 |
Why?
|
| Cytokines | 1 | 2012 | 862 | 0.070 |
Why?
|
| Animals | 6 | 2012 | 27965 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2012 | 277 | 0.070 |
Why?
|
| Comorbidity | 2 | 2023 | 1003 | 0.060 |
Why?
|
| United States | 3 | 2024 | 7581 | 0.060 |
Why?
|
| Biomarkers | 1 | 2012 | 1905 | 0.060 |
Why?
|
| Amputees | 1 | 2024 | 2 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 355 | 0.050 |
Why?
|
| Registries | 2 | 2021 | 995 | 0.050 |
Why?
|
| Relative Value Scales | 1 | 2023 | 11 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2024 | 291 | 0.050 |
Why?
|
| Walking | 1 | 2024 | 104 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 90 | 0.050 |
Why?
|
| Operative Time | 1 | 2023 | 167 | 0.050 |
Why?
|
| Medicaid | 1 | 2024 | 245 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2023 | 223 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 28 | 0.040 |
Why?
|
| Medicare | 1 | 2024 | 451 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2020 | 42 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1241 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2020 | 118 | 0.040 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 24 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2020 | 60 | 0.040 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 75 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 92 | 0.040 |
Why?
|
| Age Factors | 1 | 2024 | 1896 | 0.040 |
Why?
|
| Length of Stay | 1 | 2023 | 820 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 2705 | 0.040 |
Why?
|
| Aorta | 1 | 2020 | 273 | 0.040 |
Why?
|
| Retreatment | 1 | 2018 | 104 | 0.030 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2018 | 89 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2020 | 2562 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 2479 | 0.030 |
Why?
|
| Prognosis | 1 | 2020 | 3891 | 0.020 |
Why?
|
| Acid Phosphatase | 1 | 2012 | 28 | 0.020 |
Why?
|
| Bacterial Translocation | 1 | 2011 | 26 | 0.020 |
Why?
|
| Bacterial Adhesion | 1 | 2011 | 83 | 0.020 |
Why?
|
| Biofilms | 1 | 2012 | 50 | 0.020 |
Why?
|
| Stroke | 1 | 2020 | 1073 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2011 | 25 | 0.020 |
Why?
|
| Fungal Proteins | 1 | 2012 | 145 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 2011 | 74 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 603 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 133 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2011 | 84 | 0.020 |
Why?
|
| Symbiosis | 1 | 2011 | 128 | 0.020 |
Why?
|
| Feces | 1 | 2012 | 360 | 0.020 |
Why?
|
| Color | 1 | 2009 | 80 | 0.020 |
Why?
|
| General Surgery | 1 | 2011 | 248 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 891 | 0.020 |
Why?
|
| Iron | 1 | 2009 | 173 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2011 | 1518 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2009 | 142 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 2889 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1114 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 3815 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 27850 | 0.010 |
Why?
|
| Mutation | 1 | 2012 | 4265 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 3450 | 0.010 |
Why?
|